summary
Introduced
02/05/2026
02/05/2026
In Committee
02/17/2026
02/17/2026
Crossed Over
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Amends the Illinois Controlled Substances Act. Provides that each prescriber or the prescriber's designee shall document an attempt to access patient information in the Prescription Monitoring Program to assess patient access to controlled substances when providing a (rather than an initial) prescription for Schedule II and IV controlled substances (rather than narcotics such as opioids), except for prescriptions for oncology treatment or palliative care, or a 7-day or less supply provided by a hospital emergency department when treating an acute, traumatic medical condition.
AI Summary
This bill amends the Illinois Controlled Substances Act to require prescribers, or their designated representatives, to check the Prescription Monitoring Program (PMP) before issuing prescriptions for Schedule II and Schedule IV controlled substances, which are a category of drugs that includes substances like opioids and other pain relievers. This check is intended to assess a patient's existing access to these medications. However, this requirement has exceptions for prescriptions related to oncology treatment, palliative care, or for a supply of seven days or less provided by a hospital emergency department for acute, traumatic medical conditions. The PMP is a state-run database that tracks controlled substance prescriptions to help prevent drug diversion and "doctor shopping," where individuals try to obtain multiple prescriptions from different prescribers.
Committee Categories
Labor and Employment
Sponsors (1)
Last Action
Senate Licensed Activities Committee Hearing (13:00:00 3/11/2026 Room 400) (on 03/11/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...